DalCor Pharmaceuticals Competitors and Similar CompaniesClear all
DalCor Pharmaceuticals's competitors and similar companies include UCB, Cipla and Mankind Pharma.
 DalCor Pharmaceuticals DalCor Pharmaceuticals is company developing precision treatments for cardiovascular disease. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. | |
Founding Date | Founding Date 2015 | Founding Date 1928 | Founding Date 1935 | Founding Date 1995 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Montréal, CA HQ Zug, CH London, GB Sarasota, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations New Delhi, IN HQ |
Employees | Employees 186% increase | Employees 9,052 | Employees 27,764 | Employees 16,2532% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit ₹195b (FY, 2026) | Gross profit N/A |
Net income | Net income N/A | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 100m (about 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 215m (about 11 years ago) |
Total funding raised | Total funding raised $ 150m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 239m |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyMankind Pharma
HQ
New Delhi, IN
Employees
16,253↑ 2% increase
Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
View company